| Global epidemiology of non‐alcoholic fatty liver disease/non‐alcoholic steatohepatitis: What we need in the future AR Araújo, N Rosso, G Bedogni, C Tiribelli, S Bellentani Liver International 38, 47-51, 2018 | 432 | 2018 |
| Global multi-stakeholder endorsement of the MAFLD definition N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ... The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022 | 180 | 2022 |
| Effect of intracellular lipid accumulation in a new model of non-alcoholic fatty liver disease NC Chavez-Tapia, N Rosso, C Tiribelli BMC gastroenterology 12, 1-10, 2012 | 177 | 2012 |
| Subcellular localization of APE1/Ref-1 in human hepatocellular carcinoma: possible prognostic significance V Di Maso, C Avellini, LS Crocè, N Rosso, F Quadrifoglio, L Cesaratto, ... Molecular medicine 13, 89-96, 2007 | 124 | 2007 |
| The expression levels of the translational factors eEF1A 1/2 correlate with cell growth but not apoptosis in hepatocellular carcinoma cell lines with different differentiation … G Grassi, B Scaggiante, R Farra, B Dapas, F Agostini, D Baiz, N Rosso, ... Biochimie 89 (12), 1544-1552, 2007 | 99 | 2007 |
| Galectin-1 and its involvement in hepatocellular carcinoma aggressiveness D Spano, R Russo, V Di Maso, N Rosso, LM Terracciano, M Roncalli, ... Molecular Medicine 16, 102-115, 2010 | 98 | 2010 |
| Translational approaches: from fatty liver to non-alcoholic steatohepatitis N Rosso, NC Chavez-Tapia, C Tiribelli, S Bellentani World journal of gastroenterology: WJG 20 (27), 9038, 2014 | 84 | 2014 |
| In vitro models for the study of non-alcoholic fatty liver disease N C Chavez-Tapia, N Rosso, C Tiribelli Current medicinal chemistry 18 (7), 1079-1084, 2011 | 84 | 2011 |
| The interplay between hepatic stellate cells and hepatocytes in an in vitro model of NASH VJ Barbero-Becerra, PJ Giraudi, NC Chávez-Tapia, M Uribe, C Tiribelli, ... Toxicology in vitro 29 (7), 1753-1758, 2015 | 73 | 2015 |
| Gene and functional up-regulation of the BCRP/ABCG2 transporter in hepatocellular carcinoma CHC Sukowati, N Rosso, D Pascut, B Anfuso, G Torre, P Francalanci, ... BMC gastroenterology 12, 1-8, 2012 | 67 | 2012 |
| Hepatocyte-derived macrophage migration inhibitory factor mediates alcohol-induced liver injury in mice and patients V Marin, K Poulsen, G Odena, MR McMullen, J Altamirano, P Sancho-Bru, ... Journal of hepatology 67 (5), 1018-1025, 2017 | 65 | 2017 |
| The importance of the interaction between hepatocyte and hepatic stellate cells in fibrogenesis induced by fatty accumulation PJ Giraudi, VJB Becerra, V Marin, NC Chavez-Tapia, C Tiribelli, N Rosso Experimental and molecular pathology 98 (1), 85-92, 2015 | 65 | 2015 |
| An animal model for the juvenile non-alcoholic fatty liver disease and non-alcoholic steatohepatitis V Marin, N Rosso, M Dal Ben, A Raseni, M Boschelle, C Degrassi, ... PloS one 11 (7), e0158817, 2016 | 62 | 2016 |
| Th17 involvement in nonalcoholic fatty liver disease progression to non-alcoholic steatohepatitis CM Chackelevicius, SE Gambaro, C Tiribelli, N Rosso World journal of gastroenterology 22 (41), 9096, 2016 | 60 | 2016 |
| Hepatic cancer stem cells and drug resistance: Relevance in targeted therapies for hepatocellular carcinoma CHC Sukowati, N Rosso, LS Crocè, C Tiribelli World journal of hepatology 2 (3), 114, 2010 | 60 | 2010 |
| Effects of E2F1–cyclin E1–E2 circuit down regulation in hepatocellular carcinoma cells R Farra, B Dapas, G Pozzato, B Scaggiante, F Agostini, C Zennaro, ... Digestive and Liver Disease 43 (12), 1006-1014, 2011 | 50 | 2011 |
| Effects of oral administration of silymarin in a juvenile murine model of non-alcoholic steatohepatitis V Marin, S Gazzin, SE Gambaro, M Dal Ben, S Calligaris, M Anese, ... Nutrients 9 (9), 1006, 2017 | 41 | 2017 |
| Gene expression analysis in HBV transgenic mouse liver: a model to study early events related to hepatocarcinogenesis M Barone, D Spano, M D’Apolito, M Centra, C Lasalandra, M Capasso, ... Molecular Medicine 12, 115-123, 2006 | 40 | 2006 |
| Natural compounds for counteracting nonalcoholic fatty liver disease (NAFLD): advantages and limitations of the suggested candidates N Salvoza, PJ Giraudi, C Tiribelli, N Rosso International Journal of Molecular Sciences 23 (5), 2764, 2022 | 33 | 2022 |
| Differentiation between stages of non-alcoholic fatty liver diseases using surface-enhanced Raman spectroscopy E Gurian, P Giraudi, N Rosso, C Tiribelli, D Bonazza, F Zanconati, ... Analytica chimica acta 1110, 190-198, 2020 | 32 | 2020 |
Claudio TiribelliFondazione Italiana Fegato FIF - Italian Liver Foundation - University of Trieste在 fegato.it 的电子邮件经过验证
